|
|||
Clinical data | |||
---|---|---|---|
Trade names | Many | ||
Synonyms | NSC-43193; WIN-14833; 17α-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17β-ol | ||
AHFS/Drugs.com | Multum Consumer Information | ||
Pregnancy category |
|
||
Routes of administration |
By mouth, intramuscular injection | ||
Drug class | Androgen; Anabolic steroid | ||
ATC code | |||
Legal status | |||
Legal status |
|
||
Pharmacokinetic data | |||
Metabolism | Liver | ||
Biological half-life | ~24 hours | ||
Excretion | Kidney: 84% | ||
Identifiers | |||
|
|||
CAS Number | |||
PubChem CID | |||
DrugBank | |||
ChemSpider | |||
UNII | |||
KEGG | |||
ChEBI | |||
ChEMBL | |||
ECHA InfoCard | 100.030.801 | ||
Chemical and physical data | |||
Formula | C21H32N2O | ||
Molar mass | 328.49 g/mol | ||
3D model (JSmol) | |||
|
|||
|
|||
(what is this?) |
Stanozolol, sold under many brand names, is an androgen and anabolic steroid (AAS) medication which was derived from dihydrotestosterone (DHT). It was developed by American pharmaceutical company Winthrop Laboratories (Sterling Drug) in 1962, and has been approved by the Food and Drug Administration for human use, though it is no longer marketed in this country. It is also used in veterinary medicine. Stanozolol has mostly been discontinued, and remains available in only a few countries. It is taken by mouth or by injection into muscle.
Unlike most injectable AAS, stanozolol is not esterified and is sold as an aqueous suspension, or in oral tablet form. The drug has a high oral bioavailability, due to a C17α alkylation which allows the hormone to survive first-pass liver metabolism when ingested. It is because of this that stanozolol is also sold in tablet form.
Stanozolol is one of the AAS commonly used as performance-enhancing drugs and is banned from use in sports competition under the auspices of the International Association of Athletics Federations (IAAF) and many other sporting bodies. Additionally, stanozolol has been used in US horse racing.
Stanozolol has been used in both animals and human patients for a number of conditions. In humans, it has been demonstrated to be successful in treating anaemia and hereditary angioedema, the latter of which it has been specifically approved for the treatment of in some countries.Veterinarians may prescribe the drug to improve muscle growth, red blood cell production, increase bone density and stimulate the appetite of debilitated or weakened animals.